Experts call for clinical trials to test non-skeletal benefits of vitamin D

May 18, 2012

The Endocrine Society's new scientific statement published online today represents the first comprehensive evaluation of both the basic and clinical evidence related to the non-skeletal effects of vitamin D. The statement addresses current research regarding the associations of vitamin D with immune function, hypertension, stroke, skin conditions and maternal/fetal health.

Vitamin D is a that regulates calcium and phosphate levels in the bloodstream and promotes healthy . is common throughout the world and results in abnormalities of calcium, phosphorus and which can lead to muscle weakness, osteomalacia, osteopenia and osteoporosis. While some have shown that benefits of vitamin D may extend beyond bone health, research findings remain inconsistent.

"The role of vitamin D supplementation in the prevention and treatment of chronic non-skeletal diseases remains to be determined," says Clifford Rosen, MD, of Tufts University School of Medicine and chair of the task force that authored the statement. "We need large and dose-response data to test the effects of vitamin D on chronic disease outcomes including autoimmunity, obesity, diabetes, hypertension and heart disease."

The scientific statement outlines the evidence that defines the effects of vitamin D on epidermal, neuromuscular, maternal/fetal and neoplastic () tissues. The authors critically evaluated the literature for each organ system utilizing available evidence from observational studies and to determine the strength of associations between vitamin D and tissue-specific outcomes.

Conclusions from the statement include:

  • Topical and oral vitamin D may be useful in treating skin disorders such as psoriasis, though large-scale randomized placebo-controlled clinical trials are needed to demonstrate the efficacy of treatment with vitamin D on skin disorders or the prevention of skin cancer.
  • The ever-expanding obesity epidemic has been associated with a rising prevalence of vitamin D deficiency, but a cause-and-effect relationship has not been established. Strong evidence does not exist to support the tenet that vitamin D supplementation reduces the risk of type 2 diabetes or the metabolic syndrome.
  • Vitamin D supplementation is likely to reduce the risk of falls, particularly in individuals who have low baseline levels (<20 ng/ml) and are supplemented with calcium as well.
  • Recent systematic reviews have found that evidence that vitamin D reduces cancer incidence are inconclusive as to causality. Observational evidence is strongest for colorectal cancer but is weak or inconsistent for breast, prostate and total cancer.
  • There is a possibility that vitamin D supplementation may lower cardiovascular disease risk, but there are limitations in applying observational data to clinical practice. An insufficiency of evidence from clinical trials does not support recommending vitamin D supplementation for lowering cardiovascular disease risk at this time.
  • Clinical trials are needed to test whether vitamin D supplementation during pregnancy will prevent type 1 diabetes in offspring.
The article, "The Nonskeletal Effects of Vitamin D: An Endocrine Society Scientific Statement," appears in the June 2012 issue of The Endocrine Society's Endocrine Reviews.

Explore further: Low vitamin D levels may be common in otherwise healthy children

Related Stories

New vitamin D recommendations for older men and women

May 10, 2010

The International Osteoporosis Foundation (IOF) has released a new position statement on Vitamin D for older adults which makes important recommendations for vitamin D nutrition from an evidence-based perspective.

Recommended for you

'Business diet' a bad deal for the heart

August 19, 2016

(HealthDay)—The typical "social business diet"—heavy on red meats, sweet drinks, processed snacks and booze—takes a toll on the heart, a new study finds.

Concussion rates rising significantly in adolescents

August 18, 2016

The number of Americans diagnosed with concussions is growing, most significantly in adolescents, according to researchers at UC San Francisco. They recommend that adolescents be prioritized for ongoing work in concussion ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.